References,Sample size,Interventions,Main race,Female (%),Mean HAMA,Mean age (Year),Attrition rate (%),Sponsor,Follow-up time (weeks),Diagnosis criteria
"Boyer et al., 2004",544,placebo,NA,42,26.7,46,NA,Wyeth Research,24,dsm-iv
"Boyer et al., 2004",544,venlafaxine: 37.5 mg/day,NA,42,26.6,45,NA,Wyeth Research,24,dsm-iv
"Boyer et al., 2004",544,venlafaxine: 75 mg/day,NA,39,26.3,44,NA,Wyeth Research,24,dsm-iv
"Boyer et al., 2004",544,venlafaxine: 150 mg/day,NA,35,26.3,45,NA,Wyeth Research,24,dsm-iv
